It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Despite claims that lesional mania is associated with right-hemisphere lesions, supporting evidence is scarce, and association with specific brain areas has not been demonstrated. Here, we aimed to test whether focal brain lesions in lesional mania are more often right- than left-sided, and if lesions converge on areas relevant to mood regulation. We thus performed a systematic literature search (PROSPERO registration CRD42016053675) on PubMed and Web-Of-Science, using terms that reflect diagnoses and structures of interest, as well as lesional mechanisms. Two researchers reviewed the articles separately according to PRISMA Guidelines, selecting reports of adult-onset hypomania, mania or mixed state following a focal brain lesion, for pooled-analyses of individual patient data. Eligible lesion images were manually traced onto the corresponding MNI space slices, and lesion topography analyzed using standard brain atlases. Using this approach, data from 211 lesional mania patients was extracted from 114 reports. Among 201 cases with focal lesions, more patients had lesions involving exclusively the right (60.7%) than exclusively the left (11.4%) hemisphere. In further analyses of 56 eligible lesion images, while findings should be considered cautiously given the potential for selection bias of published lesion images, right-sided predominance of lesions was confirmed across multiple brain regions, including the temporal lobe, fusiform gyrus and thalamus. These, and several frontal lobe areas, were also identified as preferential lesion sites in comparisons with control lesions. Such pooled-analyses, based on the most comprehensive dataset of lesional mania available to date, confirm a preferential association with right-hemisphere lesions, while suggesting that several brain areas/circuits, relevant to mood regulation, are most frequently affected.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Champalimaud Centre for the Unknown, Champalimaud Clinical Centre, Lisboa, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636); Champalimaud Centre for the Unknown, Champalimaud Research, Lisboa, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636); Centro Hospitalar de Lisboa Ocidental, Department of Psychiatry and Mental Health, Lisboa, Portugal (GRID:grid.421010.6); Universidade Nova de Lisboa, NOVA Medical School | Faculdade de Ciências Médicas, Lisboa, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713)
2 Champalimaud Centre for the Unknown, Champalimaud Research, Lisboa, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636); Universidade Nova de Lisboa, NOVA Medical School | Faculdade de Ciências Médicas, Lisboa, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713); Columbia University, Department of Neuroscience, Zuckerman Mind Brain Behavior Institute, New York, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
3 Champalimaud Centre for the Unknown, Champalimaud Research, Lisboa, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636)
4 Centro Hospitalar de Lisboa Ocidental, Department of Psychiatry and Mental Health, Lisboa, Portugal (GRID:grid.421010.6)
5 Centro Hospitalar de Lisboa Ocidental, Department of Neuroradiology, Lisboa, Portugal (GRID:grid.421010.6); Hospital de Braga, Sete Fontes – São Victor, Department of Neuroradiology, Braga, Portugal (GRID:grid.421010.6)
6 University of Tübingen, Center of Neurology, Division of Neuropsychology, Hertie-Institute for Clinical Brain Research, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
7 University of Tübingen, Center of Neurology, Division of Neuropsychology, Hertie-Institute for Clinical Brain Research, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447); University of South Carolina, Department of Psychology, Columbia, USA (GRID:grid.254567.7) (ISNI:0000 0000 9075 106X)
8 Champalimaud Centre for the Unknown, Champalimaud Clinical Centre, Lisboa, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636); Groupe Henri-Mondor Albert-Chenevier, Neurosurgery and PePsy Departments, Assistance Publique-Hôpitaux de Paris (APHP), Créteil, France (GRID:grid.421010.6); Université Paris Est, Equipe 14, U955 INSERM, Institut Mondor de Recherche Biomedicale and Faculté de Médecine, Créteil, France (GRID:grid.410511.0) (ISNI:0000 0001 2149 7878)